EyePoint, Inc. Production Related Impairments or Charges
EyePoint, Inc. (EYPT) reported Production Related Impairments or Charges of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProductionRelatedImpairmentsOrCharges · last filed 2025-03-06
- EyePoint, Inc. production related impairments or charges for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- EyePoint, Inc. production related impairments or charges for fiscal 2023 was $500.00K, a 64.29% decline from fiscal 2022.
- EyePoint, Inc. production related impairments or charges for fiscal 2022 was $1.40M.
| Period end | Production Related Impairments or Charges 12 month |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-06 |
| 2023-12-31 | $500.00K 10-K · filed 2025-03-06 |
| 2022-12-31 | $1.40M 10-K · filed 2024-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |